Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma.

J Bone Oncol · 2022 · PMC9048072 · PMID 35493690

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a negative trendno p-value reported

The prognosis of patients with high-grade (G2, 3) chondrosarcoma without metastasis at initial presentation showed a negative trend in tumors with higher intratumoral 2-HG levels, although the difference was not significant ( Fig. 2 C, 2D).

also in 4,201 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.